Biorez, Inc.
http://biorez.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Biorez, Inc.
Dealmaking Quarterly Statistics, Q3 2022
During Q3, biopharma merger and acquisition value reached $15.4bn and drew in $37.6bn in potential deal value from alliances. Device company M&A values reached $550m, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $1.9bn.
$25 Million ‘Pure Fiction’ In Natrol Price Tag Made Real
Natrol owner Aurobindo asks a bankruptcy court for an order before previous owner Plethico Pharmaceuticals agrees to pay close to the price of a phantom engineering contract Plethico claimed as a debt. Aurobindo alleged Plethico sold Natrol to prevent creditors from uncovering the sham.
$25 Million ‘Pure Fiction’ In Natrol Price Tag Made Real
Natrol owner Aurobindo asks a bankruptcy court for an order before previous owner Plethico Pharmaceuticals agrees to pay close to the price of a phantom engineering contract Plethico claimed as a debt. Aurobindo alleged Plethico sold Natrol to prevent creditors from uncovering the sham.
Aurobindo Settles Dispute With Plethico Over Natrol Fraud Charges
Last year Aurobindo acquired Plethico’s Natrol dietary supplements business in the U.S., which was divested as part of court-directed bankruptcy proceedings. A few months on, the Hyderabad-based drug maker filed a case charging the seller of perpetrating fraud. Aurobindo has now informed Indian stock exchanges that it agreed to settle the matter in return for certain cash payments and transfer of assets from Plethico.
Company Information
- Industry
- Biotechnology
-
Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Soft Tissue Regeneration
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice